Pharmacyte Biotech Inc. buy Sievi
Start price
25.08.21
/
50%
€3.05
Target price
25.08.22
-
Performance (%)
-8.85%
End price
14.09.21
€2.78
Summary
This prediction ended on 14.09.21 with a price of €2.78. With a performance of -8.85%, the BUY prediction by Sievi finished with a loss. Sievi has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pharmacyte Biotech Inc. | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
According to Sievi what are the pros and cons of Pharmacyte Biotech Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Sievi for this prediction
In the thread Pharmacyte Biotech Inc. diskutieren
Buy Pharmacyte Biotech Inc.
In the thread Trading Pharmacyte Biotech Inc.
Buy beendet